CIK 0000880242 · Non-accelerated filer<br>Smaller reporting company
BIOLARGO, INC.
Sign in to watch- Ticker
- BLGO
- Exchange
- OTC
- Industry
- Chemicals & Allied Products
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 650159115
- Phone
- 888 400-2863
- Business address
- 14921 CHESTNUT ST., WESTMINSTER, CA, 92683
- Former names
- NUWAY MEDICAL INC, NUWAY ENERGY INC, LATIN AMERICAN CASINOS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-05-02 | STROMMEN JACK B. Director | Conversion · Convertible Promissory Note | −0 | $0.25 | $0 | |
| 2018-03-31 | CALVERT DENNIS P President | Grant or award | +150,197 | $0.26 | $39K | 8,300,157 |
| 2018-03-31 | Roberts Kent Charles II Director | Grant or award · Option to Purchase Common Stock | +57,916 | 1,089,005 | ||
| 2018-03-31 | CODE KENNETH REAY Chief Science Officer | Grant or award | +172,833 | $0.26 | $45K | 22,383,118 |
| 2018-03-31 | STROMMEN JACK B. Director | Grant or award · Option to Purchase Common Stock | +57,916 | 140,054 | ||
| 2018-03-31 | Runyan John S. Director | Grant or award · Option to Purchase Common Stock | +72,394 | 1,136,442 | ||
| 2018-03-31 | Marshall Dennis E Director | Grant or award · Option to Purchase Common Stock | +72,394 | 2,196,362 | ||
| 2018-03-28 | STROMMEN JACK B. Director | Purchase · Convertible Promissory Note | +0 | $100,000.00 | $0 | |
| 2018-03-28 | STROMMEN JACK B. Director | Purchase · Warrant to Purchase Common Stock | +333,333 | 3,590,476 | ||
| 2018-03-23 | STROMMEN JACK B. Director | Purchase | +110,636 | $0.27 | $30K | 655,898 |
| 2018-01-03 | STROMMEN JACK B. Director | Grant or award | +72,179 | $0.41 | $30K | 545,262 |
| 2017-12-31 | Roberts Kent Charles II Director | Grant or award · Option to Purchase Common Stock | +38,462 | 1,031,089 | ||
| 2017-12-31 | Runyan John S. Director | Grant or award · Option to Purchase Common Stock | +48,077 | 1,064,048 | ||
| 2017-12-31 | CODE KENNETH REAY Chief Science Officer | Grant or award | +71,273 | $0.39 | $28K | 22,210,285 |
| 2017-12-31 | STROMMEN JACK B. Director | Grant or award · Option to Purchase Common Stock | +38,462 | 82,138 | ||
| 2017-12-31 | CALVERT DENNIS P President | Grant or award | +77,432 | $0.39 | $30K | 8,149,960 |
| 2017-12-31 | Marshall Dennis E Director | Grant or award · Option to Purchase Common Stock | +48,077 | 2,123,968 | ||
| 2017-10-23 | PROVENZANO JOSEPH L Secretary | Grant or award · Option to Purchase Common Stock | +100,000 | 926,203 | ||
| 2017-10-12 | CALVERT DENNIS P President | Gift | −435,000 | 8,072,528 | ||
| 2017-10-12 | CODE KENNETH REAY Chief Science Officer | Gift | −120,637 | 22,139,012 |
Page 14 of 17 · 338 trades